Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Indications/Uses

Empagliflozin + Linagliptin (GLYXAMBI) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.
Limitations of Use: Empagliflozin + Linagliptin (GLYXAMBI) is not recommended for patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.
Empagliflozin + Linagliptin (GLYXAMBI) has not been studied in patients with a history of pancreatitis.

Glyxambi Indications/Uses

Manufacturer:

Boehringer Ingelheim

Distributor:

Metro Drug

Marketer:

Boehringer Ingelheim